Biotest and ADMA Biologics agree to deal for immune globulin

01/14/2013 | HealthcareGlobal.com

Biotest Pharmaceuticals has entered a 10-year deal to act as the exclusive global supplier to ADMA Biologics for respiratory syncytial virus immune globulin made from human plasma. As part of the agreement, ADMA secured the right to use Biotest's proprietary fractionation and purification technology for the production of intravenous immune globulin.

View Full Article in:

HealthcareGlobal.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD